Ultragenyx Pharmaceutical shares owned by Citadel Advisors
Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Ultragenyx Pharmaceutical
Tip: Access up to 7 years of quarterly data
All positions including Ultragenyx Pharmaceutical held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Ultragenyx Pharmaceutical by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $12M | 252k | 47.82 |
| 2023-09-30 | $1.7M | 47k | 35.65 |
| 2023-06-30 | $13M | 290k | 46.13 |
| 2023-03-31 | $23M | 571k | 40.10 |
| 2022-12-31 | $14M | 294k | 46.33 |
| 2022-06-30 | $63M | 1.1M | 59.66 |
| 2022-03-31 | $97M | 1.3M | 72.62 |
| 2021-12-31 | $122M | 1.5M | 84.09 |
| 2021-09-30 | $135M | 1.5M | 90.19 |
| 2021-06-30 | $179M | 1.9M | 95.32 |
| 2021-03-31 | $111M | 974k | 113.89 |
| 2020-12-31 | $77M | 557k | 138.42 |
| 2020-09-30 | $38M | 462k | 82.19 |
| 2020-06-30 | $54M | 689k | 78.22 |
| 2020-03-31 | $74M | 1.7M | 44.43 |
| 2019-12-31 | $65M | 1.5M | 42.71 |
| 2019-09-30 | $24M | 570k | 42.78 |
| 2019-06-30 | $35M | 549k | 63.50 |
| 2019-03-31 | $69M | 989k | 69.36 |
| 2018-12-31 | $1.4M | 33k | 43.47 |
| 2018-09-30 | $18M | 240k | 76.10 |
| 2018-06-30 | $38M | 497k | 76.92 |
| 2018-03-31 | $25M | 490k | 50.98 |
| 2017-12-31 | $14M | 300k | 46.38 |
| 2017-09-30 | $2.2M | 41k | 53.36 |
| 2017-06-30 | $1.5M | 23k | 62.17 |
| 2017-03-31 | $1.0M | 15k | 67.76 |
| 2016-12-31 | $1.1M | 16k | 70.43 |
| 2016-09-30 | $1.8M | 26k | 70.92 |
| 2016-03-31 | $24M | 380k | 63.34 |
| 2015-12-31 | $9.4M | 84k | 112.25 |
| 2015-09-30 | $5.5M | 57k | 96.30 |
| 2015-03-31 | $39M | 622k | 62.09 |
| 2014-12-31 | $16M | 373k | 43.88 |
| 2014-09-30 | $12M | 209k | 56.60 |
| 2014-06-30 | $9.3M | 207k | 44.89 |
| 2014-03-31 | $2.6M | 53k | 48.89 |